Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tourmaline Bio

Request full access

Developing transformative medicines that dramatically improve the lives of patients with life-altering immune diseases

New York City, United StatesFounded 2022Biotech & Life Sciences

About Tourmaline Bio

Tourmaline Bio is a biotechnology company focused on developing transformative medicines aimed at dramatically improving the lives of patients with life-altering immune diseases. The company operates in the biopharmaceutical market, targeting rare and significant unmet medical needs. Tourmaline Bio serves patients suffering from severe immune disorders, working closely with healthcare providers and research institutions. Their business model revolves around the research, development, and commercialization of innovative therapies. Revenue is generated through the successful development and approval of these therapies, followed by their commercialization either directly or through partnerships with larger pharmaceutical companies.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2023

Tourmaline Bio in the New York City ecosystem

Live from Dealroom

The Tourmaline Bio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

16 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • QVT Financial LP
  • Hydra Ventures
  • Petrichor

Series A3 investors entered at this stage

  • TCGX
  • Deep Track Capital
  • Cowen Healthcare Investments

Series B and later10 investors entered at this stage

  • Paradigm BioCapital
  • RA Capital Management
  • Great Point Partners
  • Acuta Capital Partners
  • Qiming Venture Partners USA
  • Braidwell
  • Affinity Asset Advisors
  • StemPoint Capital
  • KVP Capital
  • Vivo Capital
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$3M

6 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Tourmaline Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.